Rheumatology, 2-Volume Set, 6th Edition
"..a spectacular and seemingly comprehensive review of rheumatology." Reviewed by Dr. Harry Brown, on behalf of glycosmedia.com, December 2014Table of Contents
New to This Edition
- Remain up to date on the latest information in rheumatology through 13 brand-new chapters covering biomedical and translation science, disease and outcome assessment, new imaging modalities, early emerging disease, clinical therapeutics, patient management, and rehabilitation.
- Take advantage of expanded coverage of small molecule treatment, biologics, biomarkers, epigenetics, biosimilars, and cell-based therapies.
- Focus on the core knowledge needed for successful results with each chapter co-authored by an internationally-renowned specialist in the field.
- Easily find the information you need thanks to a consistent, user-friendly format with templated content and large-scale images.
- Access the full text online at Expert Consult.
- Track disease progression and treat patients more effectively with the information on genetic findings, imaging outcomes, cell and biologic therapies, rheumatoid arthritis, and SLE.
- Incorporate recent findings about pathogenesis of disease; imaging outcomes for specific diseases like RA, osteoarthritis, and spondyloarthropathies; cell and biologic therapies; and other timely topics.
"My lasting impression of this book was the very same as the first time I opened these two lavish volumes and that was - wow! This two volume set is a spectacular and seemingly comprehensive review of rheumatology. Now in its sixth edition, it is a huge production with a large number of contributors from numerous countries all over the world. It is expertly edited and seamlessly put together. There is plenty of good basic and interesting yet relevant science here as well as a seemingly comprehensive review of the clinical aspects of rheumatology. I would suspect this is the nearest you would get to an encyclopaedia of rheumatology." Reviewed by Dr. Harry Brown, on behalf of glycosmedia.com, December 2014
By Marc C. Hochberg, MD, MPH, Professor of Medicine and Epidemiology and Preventative Medicine; Head, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA ; Alan J. Silman, MD, ARC Professor of Rheumatic Disease Epidemiology, Director, ARC Epidemiology Research Unit, University of Manchester, UK; Josef S. Smolen, MD, Professor of Medicine, Chairman, Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna; Chairman, Second Department of Medicine, Center for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria ; Michael E. Weinblatt, MD, John R. and Eileen K. Riedman Professor of Medicine, Harvard Medical School; Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, Massachusetts, USA and Michael H. Weisman, MD, Chief, Division of Rheumatology, Professor of Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine and UCLA, Los Angeles, California, UA